Alpha Teknova, Inc.
NASDAQ:TKNODrug Manufacturers - Specialty & Generic
+$0.23 today
- Market cap
- $495.68M
- Beta
- 0.63
- P/E (TTM)
- -16.2
- EPS (TTM)
- -$0.32
Volume 0.30M
Average 0.13M
TKNO Sales of Investments
Cash received from selling or redeeming investments.
Alpha Teknova, Inc.NASDAQ: TKNO
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments grows, but more slowly than its trailing trend
Q1 FY2026 sales of investments of $6M rose 0.0% year over year, behind the +383.3% change in trailing-twelve-month sales of investments. Sequentially, it fell 14.3% from the prior quarter.
Context
- Sales of investments amounted to 71.6% of revenue in FY2025, up 61.0 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +0.0% toward the trailing-twelve-month pace of +383.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 29M USD
- Year-over-year change
- +625.0%
- 4-year CAGR
- +99.6%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 29M | +625.0% |
| FY2024 | 2024-12-31 | 4M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 1.83M | — |
Sales of Investments vs competitors
How TKNO compares with its peers on the latest reported figures
- TKNO's LTM Mar 2026 sales of investments of $29M is the 5th largest of the 8 companies compared; the peer median is $40M.
- Its year-over-year change of +383.3% is the highest of 5, against a peer median of -41.8%.
- Sales of investments amounts to 69.4% of revenue for TKNO, versus a peer median of 17.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $328.61M | -16.8% | -33.0% | 52.9% | |
| LTM Jun 2026 | $135.64M | — | — | 17.3% | |
| LTM Mar 2026 | $56.36M | +211.2% | +67.1% | 56.5% | |
| LTM Mar 2026 | $40M | -82.5% | — | 46.4% | |
| LTM Mar 2026 | $29M | +383.3% | — | 69.4% | |
| LTM Sep 2026 | $1.99M | -66.8% | -61.8% | 0.2% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TKNO) | $40M | -41.8% | -33.0% | 17.3% | |
Competitors are the stored peer set for TKNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.8M) | (47.47M) | (36.78M) | (26.75M) | (17.26M) |
| Depreciation & Amortization | 2.88M | 3.17M | 5.66M | 6.58M | 6.34M |
| Deferred Income Tax | (2.84M) | (1.93M) | (304K) | (92K) | 52K |
| Stock-Based Compensation | 1.55M | 3.71M | 4.14M | 3.67M | 3.43M |
| Change in Working Capital | (1.77M) | (7.33M) | 2.25M | (873K) | (2.68M) |
| Accounts Receivables | (49K) | 380K | 314K | (494K) | (374K) |
| Inventory | (2.25M) | (7.55M) | 330K | 244K | (2.37M) |
| Accounts Payables | 270K | 572K | (773K) | (594K) | 470K |
| Other Working Capital | 263K | (736K) | 2.38M | (29K) | (407K) |
| Other Non-Cash Items | 906K | 22.46M | 6.22M | 5.08M | 1.47M |
| Operating Cash Flow | (9.07M) | (27.4M) | (18.81M) | (12.39M) | (8.65M) |
| Capital Expenditures | (19.88M) | (28.15M) | (7.93M) | (1.13M) | (1.15M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (30.28M) | (17.15M) |
| Sales of Investments | 1.83M | 0 | 0 | 4M | 29M |
| Other Investing Activities | 529K | 0 | 197K | 125K | 0 |
| Investing Cash Flow | (17.52M) | (28.15M) | (7.74M) | (27.28M) | 10.7M |
| Debt Repayment | 11.89M | 10.14M | (10M) | 0 | 1.11M |
| Common Stock Issued | 102.67M | 439K | 22.5M | 15.1M | 211K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.77M) | (307K) | (32K) | (214K) | (1.17M) |
| Financing Cash Flow | 110.79M | 10.27M | 12.8M | 14.89M | 151K |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 84.2M | (45.28M) | (13.75M) | (24.78M) | 2.2M |
| Free Cash Flow | (28.95M) | (55.55M) | (26.75M) | (13.52M) | (9.79M) |
Alpha Teknova, Inc.
NASDAQ:TKNO
Intrinsic Alpha fair value
Locked
Current Price
$7.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.